Key points are not available for this paper at this time.
The commercial applications of polymers produced by reversible-deactivation radical polymerization are reviewed here.
Mathias Destarac (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: